it's great to see trial progressing as per plan... it'll be interesting to see how slide 13 progresses (Trial is definitely priority 1) i.e. expansion into other cancer tumors.
Also, remember medical trials are a slow process but any biotech given trial approval by FDA comes on the radar of every big pharma company and i am certain their scouts are keeping a very close watch on this one...!
Ann: Successful Completion of Dosing in First Patient Cohort, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.76K | 2.928M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4817793 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18563373 | 21 |
View Market Depth
| Last trade - 14.13pm 26/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |